BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33030132)

  • 21. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus.
    Chung CP; Oeser A; Avalos I; Raggi P; Stein CM
    Lupus; 2006; 15(9):562-9. PubMed ID: 17080910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Yildirim N
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11508-11516. PubMed ID: 38095398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    Dessie G
    PLoS One; 2022; 17(6):e0269431. PubMed ID: 35657933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
    Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
    Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.
    Sivakumaran J; Harvey P; Omar A; Tayer-Shifman O; Urowitz MB; Gladman DD; Anderson N; Su J; Touma Z
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 34045359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.
    Choi MY; Guan H; Yoshida K; Paudel M; Kargere BA; Li D; Ellrodt J; Stevens E; Cai T; Weber BN; Everett BM; Costenbader KH
    Semin Arthritis Rheum; 2024 Aug; 67():152468. PubMed ID: 38788567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary plaque progression is greater in systemic lupus erythematosus than rheumatoid arthritis.
    Moore J; Lakshmanan S; Manubolu VS; Kinninger A; Stojan G; Goldman DW; Petri M; Budoff M; Karpouzas GA
    Coron Artery Dis; 2023 Jan; 34(1):52-58. PubMed ID: 36421035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Louthrenoo W; Ruttanaumpawan P; Aramrattana A; Sukitawut W
    QJM; 1999 Feb; 92(2):97-102. PubMed ID: 10209661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis].
    Gawrysiak W; Skrypnik K; Suliburska J; Skrypnik D; Bogdański P
    Przegl Lek; 2017; 74(4):179-82. PubMed ID: 29696959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.
    Restivo V; Candiloro S; Daidone M; Norrito R; Cataldi M; Minutolo G; Caracci F; Fasano S; Ciccia F; Casuccio A; Tuttolomondo A
    Autoimmun Rev; 2022 Jan; 21(1):102925. PubMed ID: 34454117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk.
    Sieiro Santos C; Oliveira MM; Solari PN; Mateus P; Santos MJ; Corominas H; Castro CÁ; Álvarez ED
    Reumatol Clin (Engl Ed); 2024 May; 20(5):229-236. PubMed ID: 38880551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study.
    Sacre K; Escoubet B; Pasquet B; Chauveheid MP; Zennaro MC; Tubach F; Papo T
    PLoS One; 2014; 9(4):e94511. PubMed ID: 24722263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases.
    Cohen MG; Webb J
    Ann Rheum Dis; 1987 Nov; 46(11):853-8. PubMed ID: 3426291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.
    Divard G; Abbas R; Chenevier-Gobeaux C; Chanson N; Escoubet B; Chauveheid MP; Dossier A; Papo T; Dehoux M; Sacre K
    Arthritis Res Ther; 2017 Jun; 19(1):132. PubMed ID: 28610589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus.
    Ronda N; Favari E; Borghi MO; Ingegnoli F; Gerosa M; Chighizola C; Zimetti F; Adorni MP; Bernini F; Meroni PL
    Ann Rheum Dis; 2014 Mar; 73(3):609-15. PubMed ID: 23562986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Siwan Traditional Therapy on Erythrocyte Sedimentation Rate, Lipid Profile, and Atherogenic Index as Cardiac Risk Factors Related to Rheumatoid Arthritis.
    Mahmoud NF; Allam NM; Omara II; Fouda HA
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676677
    [No Abstract]   [Full Text] [Related]  

  • 40. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
    Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.